Corcept Therapeutics Incorporated (CORT): Price and Financial Metrics

Corcept Therapeutics Incorporated (CORT): $23.51

0.31 (-1.30%)

POWR Rating

Component Grades








Add CORT to Watchlist
Sign Up

Industry: Biotech




#6 of 360

in industry

CORT Price/Volume Stats

Current price $23.51 52-week high $34.28
Prev. close $23.82 52-week low $20.87
Day low $23.31 Volume 426,800
Day high $23.82 Avg. volume 1,486,624
50-day MA $23.75 Dividend yield N/A
200-day MA $26.54 Market Cap 2.43B

CORT Stock Price Chart Interactive Chart >

Corcept Therapeutics Incorporated (CORT) Company Bio

Corcept Therapeutics engages in the discovery, development, and commercialization of drugs for the treatment of metabolic, oncologic, and psychiatric disorders. The company was founded in 1998 and is based in Menlo Park, California.

CORT Latest News Stream

Event/Time News Detail
Loading, please wait...

CORT Latest Social Stream

Loading social stream, please wait...

View Full CORT Social Stream

Latest CORT News From Around the Web

Below are the latest news stories about CORCEPT THERAPEUTICS INC that investors may wish to consider to help them evaluate CORT as an investment opportunity.

Corcept Therapeutics Inc's Chief Development Officer Sells Shares

On December 22, 2023, Chief Development Officer William Guyer sold 10,000 shares of Corcept Therapeutics Inc (NASDAQ:CORT), as reported in a recent SEC Filing.

Yahoo | December 24, 2023

Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Could Be 36% Below Their Intrinsic Value Estimate

Key Insights Corcept Therapeutics' estimated fair value is US$41.23 based on 2 Stage Free Cash Flow to Equity Corcept...

Yahoo | December 11, 2023

Here's Why Corcept Therapeutics (CORT) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Yahoo | December 8, 2023

Nektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue?

Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 7, 2023

Insider Sell: Joseph Lyon of Corcept Therapeutics Inc (CORT) Sells 5,000 Shares

Joseph Lyon, the Chief Accounting Officer of Corcept Therapeutics Inc, has recently made a significant stock transaction, selling 5,000 shares of the company on December 4, 2023.

Yahoo | December 7, 2023

Read More 'CORT' Stories Here

CORT Price Returns

1-mo 1.21%
3-mo N/A
6-mo -17.01%
1-year 6.04%
3-year 2.48%
5-year 99.58%
YTD -27.62%
2023 59.92%
2022 2.58%
2021 -24.31%
2020 116.20%
2019 -9.43%

Continue Researching CORT

Here are a few links from around the web to help you further your research on Corcept Therapeutics Inc's stock as an investment opportunity:

Corcept Therapeutics Inc (CORT) Stock Price | Nasdaq
Corcept Therapeutics Inc (CORT) Stock Quote, History and News - Yahoo Finance
Corcept Therapeutics Inc (CORT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!